Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

2.9K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

644
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
644
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

944
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
944

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same author

Are There Connections between the Neuroendocrine and Dopamine Systems in Bipolar Disorder?

Neuroendocrinology·2025
Same author

The Immunometabolic Gene N-Acetylglucosamine Kinase Is Uniquely Involved in the Heritability of Multiple Sclerosis Severity.

International journal of molecular sciences·2024
Same author

The genomic landscape of mammal domestication might be orchestrated by selected transcription factors regulating brain and craniofacial development.

Development genes and evolution·2023
Same author

Irrespective of Plaque Activity, Multiple Sclerosis Brain Periplaques Exhibit Alterations of Myelin Genes and a TGF-Beta Signature.

International journal of molecular sciences·2022
Same author

Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.

International journal of molecular sciences·2021

Related Experiment Video

Updated: Aug 13, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K

Myelinodegeneration vs. Neurodegeneration in MS Progressive Forms.

Serge Nataf1,2,3

  • 1Bank of Tissues and Cells, Hospices Civils de Lyon, Hôpital Edouard Herriot, Place d'Arsonval, F-69003 Lyon, France.

International Journal of Molecular Sciences
|January 21, 2023
PubMed
Summary

Multiple Sclerosis (MS) involves progressive neurological decline due to neuronal death, axonal damage, and synaptic dysfunction. Understanding these mechanisms is key to developing effective treatments for progressive MS patients.

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.2K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K

Related Experiment Videos

Last Updated: Aug 13, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.2K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

27.2K

Area of Science:

  • Neuroscience
  • Neurology
  • Immunology

Background:

  • Progressive Multiple Sclerosis (MS) is characterized by gradual neurological function deterioration.
  • This decline is attributed to a complex interplay of neuronal cell death, axonal damage, and synaptic dysfunction.

Discussion:

  • Investigating the specific molecular and cellular pathways driving these pathological processes in progressive MS is crucial.
  • Understanding the combined effects of neurodegeneration and synaptic failure is essential for therapeutic development.

Key Insights:

  • The progressive nature of MS involves multifaceted neurodegenerative processes.
  • Axonal integrity and synaptic function are critical targets for intervention in MS.

Outlook:

  • Future research should focus on integrated therapeutic strategies targeting neuronal survival, axonal repair, and synaptic plasticity.
  • Developing biomarkers to monitor these specific pathological changes could aid in personalized treatment approaches for MS.